Inhibiting Mst1 in multiple ways, such as the pharmaceutical inhibitor XMU-MP-1 or transgenic mice, improves glucose tolerance and heart function in a diabetic mouse model (125–129), whereas the overexpression of MST1 impairs cardiac function and exacerbates insulin resistance (128, 130). Here, MST1 is linked to Insulin resistance.